Insufflation Unit Recall: Olympus Removes High Flow Insufflation Units

FDA’s Center for Drug Evaluation and Research (CDER) and Center for Biologics Evaluation and Research (CBER) have accepted the agency’s first submission into the Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

On September 30, 2022, the President signed into law the FDA User Fee Reauthorization Act of 2022.

FDA strongly encourages companies to continue to develop new, reliable ways to minimize animal testing and to provide the data necessary for the FDA to make a GRASE determination for sunscreen active ingredients.

This technical specifications document represents the Food and Drug Administration’s (FDA’s) current thinking on this topic.

Adulterated Human Foods/Misbranded

Learn about the warnings for sleep, skin and bodybuilding products that contain hidden drugs and other hidden ingredients.